University of Turin, Clinica Ortopedica I, CTO Hospital Via Zuretti 29, 10126, Turin, Italy.
University of Turin, Clinica Ortopedica I, CTO Hospital Via Zuretti 29, 10126, Turin, Italy.
Injury. 2019 Aug;50 Suppl 4:S47-S55. doi: 10.1016/j.injury.2019.01.016. Epub 2019 Jan 23.
Resorbable osteosynthesis has been used in orthopaedic surgery for many years. However, indications for the use of these implants in the surgery of traumatic lesions of the foot have not yet been clearly defined. The aim of this study is to analyse reported experiences with the bioabsorbable devices and to suggest guidelines for their use in foot trauma surgery METHODS: We conducted a literature review to identify known indications for the use of absorbable devices in traumatic lesions of the foot. We also conducted a retrospective analysis of our registry, reviewing patients with traumatic lesions of the foot who were treated surgically with absorbable devices from November 2005 to January 2017. To this end, we analysed for each case the indication for the use of resorbable devices and the incidence of related complications.
Only 14 relevant studies were found. In the selected period, 76 patients were treated using bioabsorbable devices for a traumatic lesion of the foot. Nine patients were lost to follow-up or did not satisfy the inclusion criteria. Therefore, the final size of the registry was 67 patients. The average follow-up was 20.5 months (range 6-66). All the bioabsorbable devices used were screws and bars of poly-L-lactic acid (PLLA). The indications identified in the literature review and in our registry were osteosynthesis of small periarticular fragments in talus and calcaneus fractures, preliminary stabilisation of articular fragments in Sanders III calcaneal fractures and fracture-dislocations of the Lisfranc or Chopart joints. No foreign-body reactions occurred. However, in one case we registered a late mobilisation of a PLLA bar in a healed calcaneal fracture, probably as a consequence of surgical malpositioning of the device. All the operated lesions demonstrated a normal healing time, and the complication rate was comparable with those of other types of osteosynthesis.
In foot trauma surgery the use of absorbable devices can give advantages. The most clearly defined indications are osteosynthesis of peri-articular or articular fragments in talus and calcaneus fractures, Sanders III calcaneal fractures and fracture-dislocations of Lisfranc's or Chopart's joints. Foreign-body reactions are rare and seem not to present a problem.
可吸收内固定物在骨科手术中已应用多年。然而,其在足部创伤性病变手术中的应用指征尚未明确。本研究旨在分析可吸收内固定物的应用经验,并提出其在足部创伤手术中的应用指南。
我们对已知的可吸收内固定物在足部创伤性病变中的应用指征进行了文献回顾,并对 2005 年 11 月至 2017 年 1 月期间使用可吸收内固定物治疗的足部创伤患者进行了回顾性分析。为此,我们对每个病例使用可吸收内固定物的适应证和相关并发症的发生率进行了分析。
仅发现 14 项相关研究。在选定的时间段内,76 例足部创伤患者使用生物可吸收装置进行治疗。9 例患者失访或不符合纳入标准。因此,注册研究的最终样本量为 67 例。平均随访时间为 20.5 个月(6-66 个月)。所有使用的生物可吸收装置均为聚-L-乳酸(PLLA)螺钉和棒。文献复习和我们的注册研究中确定的适应证包括距骨和跟骨骨折的小关节周围碎片的骨内固定、Sanders III 型跟骨骨折中关节碎片的初步稳定、Lisfranc 或 Chopart 关节的骨折脱位。未发生异物反应。然而,在 1 例跟骨愈合骨折中,我们发现 PLLA 棒出现延迟活动,可能是由于手术中内固定物的位置不当所致。所有接受手术的病变均正常愈合,并发症发生率与其他类型的内固定物相当。
在足部创伤手术中,使用可吸收内固定物可带来优势。最明确的适应证是距骨和跟骨骨折、Sanders III 型跟骨骨折、Lisfranc 或 Chopart 关节骨折脱位的关节周围或关节内碎片的骨内固定。异物反应罕见,似乎不是问题。